Evidence map›Paper›PMID 35217711›Full record

ArticleNPJ precision oncology2022

Single-cell spatial architectures associated with clinical outcome in head and neck squamous cell carcinoma.

Katie E Blise, Shamilene Sivagnanam, Grace L Banik, Lisa M Coussens, Jeremy Goecks

Open access · goldAbstract read
In one paragraph

Article in NPJ precision oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
5.1field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 52 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Spatial proteomics: technical evolution and applications in cancer research.Frontiers in cell and developmental biology · 2026
    Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Immune cell topography of head and neck cancer.Journal for immunotherapy of cancer · 2024
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Katie E BliseDepartment of Biomedical Engineering, Oregon Health & Science University, Portland, OR, USA.ORCID http://orcid.org/0000-0002-6433-9455
Shamilene SivagnanamThe Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA.ORCID http://orcid.org/0000-0001-5966-1522
Grace L BanikDepartment of Cell, Developmental & Cancer Biology, Oregon Health & Science University, Portland, OR, USA.ORCID http://orcid.org/0000-0002-0075-4334
Lisa M CoussensThe Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA.ORCID http://orcid.org/0000-0003-2389-1865
Jeremy GoecksDepartment of Biomedical Engineering, Oregon Health & Science University, Portland, OR, USA. goecksj@ohsu.edu.ORCID http://orcid.org/0000-0002-4583-5226
Oregon Health & Science University · USChildren's Hospital of Philadelphia · US

Funding

Omic and Multidimensional Spatial Atlas of Metastatic Breast CancerU2CCA233280 · NCI · OREGON HEALTH & SCIENCE UNIVERSITY · PI GOECKS, JEREMY · 2018 to 2023
$9.7M
Therapeutic Targeting of Macrophage PI3Kgamma in HNSCCR01CA226909 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Kathryn Ann Gold, Judith A VARNER · 2018 to 2026
$3.9M
A Federated Galaxy for user-friendly large-scale cancer genomics researchU24CA231877 · NCI · OREGON HEALTH & SCIENCE UNIVERSITY · PI GOECKS, JEREMY, SCHATZ, MICHAEL · 2018 to 2022
$3.9M
Comparative analysis between patient-derived models of pancreatic ductal adenocarcinomas and matched tumor specimensU01CA224012 · NCI · OREGON HEALTH & SCIENCE UNIVERSITY · PI BRODY, JONATHAN, COUSSENS, LISA M. · 2019 to 2023
$2.9M
Integrated Training in Quantitative and Experimental Cancer Systems BiologyT32CA254888 · NCI · OREGON HEALTH & SCIENCE UNIVERSITY · PI Sudarshan Anand, LISA M COUSSENS · 2021 to 2026
$2.2M
In Situ characterization and manipulation of tumor immune cell metabolomics using implantable microdevicesR01CA223150 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · PI JONAS, OLIVER · 2018 to 2022
$1.9M
Mechanisms of metabolic dysfunction in the offspring of maternal obesity: role of inflammationR21HD099367 · NICHD · OREGON HEALTH & SCIENCE UNIVERSITY · PI MALOYAN, ALINA · 2019 to 2020
$411k
NCI NIH HHS R01 CA223150NCI NIH HHS R01 CA226909NCI NIH HHS T32 CA254888NCI NIH HHS U01 CA224012NCI NIH HHS U24 CA231877NCI NIH HHS U2C CA233280NICHD NIH HHS R21 HD099367U.S. Department of Health & Human Services | NIH | National Cancer Institute (NCI) R01CA223150U.S. Department of Health & Human Services | NIH | National Cancer Institute (NCI) R01CA226909U.S. Department of Health & Human Services | NIH | National Cancer Institute (NCI) R21HD099367U.S. Department of Health & Human Services | NIH | National Cancer Institute (NCI) T32CA254888U.S. Department of Health & Human Services | NIH | National Cancer Institute (NCI) U01CA224012U.S. Department of Health & Human Services | NIH | National Cancer Institute (NCI) U2CCA233280
6 · The paper itself

Abstract

There is increasing evidence that the spatial organization of cells within the tumor-immune microenvironment (TiME) of solid tumors influences survival and response to therapy in numerous cancer types. Here, we report results and demonstrate the applicability of quantitative single-cell spatial proteomics analyses in the TiME of primary and recurrent human papillomavirus (HPV)-negative head and neck squamous cell carcinoma (HNSCC) tumors. Single-cell compositions of a nine patient, primary and recurrent (n = 18), HNSCC cohort is presented, followed by deeper investigation into the spatial architecture of the TiME and its relationship with clinical variables and progression free survival (PFS). Multiple spatial algorithms were used to quantify the spatial landscapes of immune cells within TiMEs and demonstrate that neoplastic tumor-immune cell spatial compartmentalization, rather than mixing, is associated with longer PFS. Mesenchymal (αSMA

Identifiers

PMID35217711
PMCPMC8881577
OpenAlexW4214751350

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.